Muhammad Abdur Rahman Afridi
Muhammad Abdur Rahman Afridi publishes mostly in Infectious Diseases, Epidemiology and Surgery, on topics such as COVID-19 Clinical Research Studies, SARS-CoV-2 and COVID-19 Research and Liver Disease Diagnosis and Treatment.
- World rank
- #1,750,197 of 7,710,434 ranked researchers
- Rank in Pakistan
- #5,631 of 32,975
- Works
- 38
- Citations
- 2.3k
- Citations per work
- 59.6
What does Muhammad Abdur Rahman Afridi research?
Muhammad Abdur Rahman Afridi's work is mostly in Medicine (70%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences2770.0%
- Medicine2770.0%
- Everything else1130.0%
- 1Infectious Diseases27% of their works
- 2Epidemiology11% of their works
- 3Surgery10% of their works
- 4Neurology9% of their works
- 5Endocrinology, Diabetes and Metabolism9% of their works
- 6Hepatology5% of their works
Research topics
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
- Liver Disease Diagnosis and Treatment
- Long-Term Effects of COVID-19
- Liver Disease and Transplantation
- Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Hepatitis B Virus Studies
Which keywords describe Muhammad Abdur Rahman Afridi's research?
The keywords of their largest research topics: ACE2 Receptor, SARS-CoV-2, Immune Response, Clinical Characteristics, Epidemiology, Coronavirus, Insulin Resistance and Metabolic Syndrome.
- Diabetes
- Cardiovascular Disease
- Hyperglycemia
- Hepatic Encephalopathy
- Neurologic Manifestations
- NAFLD
- Metabolic Syndrome
- Coronavirus
- Clinical Characteristics
- SARS-CoV-2
- ACE2 Receptor
- Immune Response
- Epidemiology
- Insulin Resistance
- Vaccine
- NASH
- Post-acute COVID-19 Syndrome
- Liver Cirrhosis
- Insulin Therapy
- Chronic Hepatitis B
- Hepatitis B Virus
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 21 words, with their numbers
- ACE2 Receptor202 topics
- SARS-CoV-2202 topics
- Immune Response152 topics
- Clinical Characteristics131 topic
- Epidemiology131 topic
- Coronavirus71 topic
- Insulin Resistance72 topics
- Metabolic Syndrome72 topics
- Vaccine71 topic
- NAFLD51 topic
- NASH51 topic
- Neurologic Manifestations51 topic
- Post-acute COVID-19 Syndrome51 topic
- Hepatic Encephalopathy41 topic
- Liver Cirrhosis41 topic
- Hyperglycemia31 topic
- Insulin Therapy31 topic
- Cardiovascular Disease21 topic
- Chronic Hepatitis B21 topic
- Diabetes21 topic
- Hepatitis B Virus21 topic
Where does Muhammad Abdur Rahman Afridi work?
Muhammad Abdur Rahman Afridi's main affiliation in the publication record is Lady Reading Hospital, Pakistan.
How many publications and citations does Muhammad Abdur Rahman Afridi have?
OpenAlex counts 38 works and 2,263 citations for Muhammad Abdur Rahman Afridi, an h-index of 9, ranking #1,750,197 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Muhammad Abdur Rahman Afridi. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.